Virus-sharing draft agreement very close; U.S. yet to formally approve, Reuters reports

NewsGuard 100/100 Score

A draft agreement that would ensure countries would share virus samples in exchange for access to affordable vaccines derived from such samples in the event of a pandemic is nearly complete, senior diplomats told Reuters on Thursday. "Consensus has been reached across all regions, including Indonesia which three years ago stopped sharing influenza samples with the World Health Organization (WHO), but the United States has yet to give formal approval, they said," according to the news service.

"The U.S. delegation is checking with Washington overnight but the U.S. ambassador has recommended going along," one ambassador said late Thursday. The WHO working group tasked with creating the draft had hoped to reach a deal by Friday, so that it could be on during next month's World Health Assembly, scheduled for May 16-24.

"The working group's draft document calls for having deals in place ahead of the next pandemic, including pre-purchase agreements with industry and governments to reserve a certain percentage of production capacity, for example 10 percent, earmarked for countries without access to vaccines," according to Reuters (Nebehay, 5/15).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough in gene editing: Enhanced virus-like particles promise new era in genetic disease treatment